174 related articles for article (PubMed ID: 20878981)
1. Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.
Fujita K; Ewing CM; Isaacs WB; Pavlovich CP
Int J Cancer; 2011 Jul; 129(2):424-32. PubMed ID: 20878981
[TBL] [Abstract][Full Text] [Related]
2. N-3 polyunsaturated fatty acids inhibit IFN-γ-induced IL-18 binding protein production by prostate cancer cells.
Wang X; Breeze A; Kulka M
Cancer Immunol Immunother; 2015 Feb; 64(2):249-58. PubMed ID: 25351720
[TBL] [Abstract][Full Text] [Related]
3. Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus.
Migliorini P; Anzilotti C; Pratesi F; Quattroni P; Bargagna M; Dinarello CA; Boraschi D
Eur Cytokine Netw; 2010 Dec; 21(4):264-71. PubMed ID: 21126942
[TBL] [Abstract][Full Text] [Related]
4. The IL-18 antagonist IL-18-binding protein is produced in the human ovarian cancer microenvironment.
Carbotti G; Barisione G; Orengo AM; Brizzolara A; Airoldi I; Bagnoli M; Pinciroli P; Mezzanzanica D; Centurioni MG; Fabbi M; Ferrini S
Clin Cancer Res; 2013 Sep; 19(17):4611-20. PubMed ID: 23873689
[TBL] [Abstract][Full Text] [Related]
5. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of IL-18 binding protein and IL-4 regulates Th1/Th2 cytokine response in murine collagen-induced arthritis.
Leng J; Yao H; Shen J; Wang K; Zhuo G; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):116-24. PubMed ID: 18235973
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants.
Zecchina G; Novick D; Rubinstein M; Barak V; Dinarello C; Nagler A
J Hematother Stem Cell Res; 2001 Dec; 10(6):769-76. PubMed ID: 11798503
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-18 and IL-18BP levels in patients with Chikungunya virus infection.
Chirathaworn C; Rianthavorn P; Wuttirattanakowit N; Poovorawan Y
Viral Immunol; 2010 Feb; 23(1):113-7. PubMed ID: 20121409
[TBL] [Abstract][Full Text] [Related]
9. Endoglin (CD105) as a urinary and serum marker of prostate cancer.
Fujita K; Ewing CM; Chan DY; Mangold LA; Partin AW; Isaacs WB; Pavlovich CP
Int J Cancer; 2009 Feb; 124(3):664-9. PubMed ID: 19004009
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
Tassidis H; Brokken LJ; Jirström K; Ehrnström R; Pontén F; Ulmert D; Bjartell A; Härkönen P; Wingren AG
Int J Cancer; 2010 May; 126(10):2296-307. PubMed ID: 19795453
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 18 and interleukin 18 binding protein: possible role in immunosuppression of chronic renal failure.
Dinarello CA; Novick D; Rubinstein M; Lonnemann G
Blood Purif; 2003; 21(3):258-70. PubMed ID: 12784053
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.
Shariat SF; Andrews B; Kattan MW; Kim J; Wheeler TM; Slawin KM
Urology; 2001 Dec; 58(6):1008-15. PubMed ID: 11744478
[TBL] [Abstract][Full Text] [Related]
13. High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura.
Shan NN; Zhu XJ; Wang Q; Wang CY; Qin P; Peng J; Hou M
Haematologica; 2009 Nov; 94(11):1603-7. PubMed ID: 19797730
[TBL] [Abstract][Full Text] [Related]
14. Blood Interleukin-18 (IL-18) and IL-18 Binding Protein (IL-18BP) Levels Following Midline Laparotomy: A Prospective Randomized Study of Patients With Benign Disease and Patients With Cancer.
Eskelinen M; Selander T; Pulkkinen J; Hämäläinen E; Eskelinen M
Anticancer Res; 2024 May; 44(5):2039-2046. PubMed ID: 38677734
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis.
Shao XT; Feng L; Gu LJ; Wu LJ; Feng TT; Yang YM; Wu NP; Yao HP
Clin Exp Med; 2009 Sep; 9(3):215-21. PubMed ID: 19225717
[TBL] [Abstract][Full Text] [Related]
16. Elevated IL-37, IL-18 and IL-18BP serum concentrations in patients with primary Sjögren's syndrome.
Liuqing W; Liping X; Hui S; Jing L
J Investig Med; 2017 Mar; 65(3):717-721. PubMed ID: 28057714
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.
Banda NK; Vondracek A; Kraus D; Dinarello CA; Kim SH; Bendele A; Senaldi G; Arend WP
J Immunol; 2003 Feb; 170(4):2100-5. PubMed ID: 12574381
[TBL] [Abstract][Full Text] [Related]
18. Interfering with interferon-γ signalling in intestinal epithelial cells: selective inhibition of apoptosis-maintained secretion of anti-inflammatory interleukin-18 binding protein.
Schuhmann D; Godoy P; Weiss C; Gerloff A; Singer MV; Dooley S; Böcker U
Clin Exp Immunol; 2011 Jan; 163(1):65-76. PubMed ID: 21078084
[TBL] [Abstract][Full Text] [Related]
19. The effects of IL-18BP on mRNA expression of inflammatory cytokines and apoptotic genes in renal injury induced by infrarenal aortic occlusion.
Gönül Y; Genç A; Ahsen A; Bal A; Hazman Ö; Toktaş M; Ulu MS; Özdinç Ş; Songur A
J Surg Res; 2016 May; 202(1):33-42. PubMed ID: 27083945
[TBL] [Abstract][Full Text] [Related]
20. IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice.
Faggioni R; Cattley RC; Guo J; Flores S; Brown H; Qi M; Yin S; Hill D; Scully S; Chen C; Brankow D; Lewis J; Baikalov C; Yamane H; Meng T; Martin F; Hu S; Boone T; Senaldi G
J Immunol; 2001 Nov; 167(10):5913-20. PubMed ID: 11698468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
